Dykema (Cannabis Law Blog)

APRIL 20, 2023

In recent years, most major cities in Texas have launched programs and adopted policies that reduce, or even eliminate, penalties for the possession of cannabis. [ii] iv] Currently, the Act permits a qualified physician to prescribe “low-THC cannabis” (1% by weight tetrahydrocannabinol (“THC”)) for a greater number of conditions. [v]

Law 74

Law Chronic Pain Conditions Medicine 74

Veriheal

MARCH 20, 2023

Psilocybin Policies Around the Nation Let’s explore where psilocybin is legal, decriminalized, and on the ballot across U.S. The state bill would start the process of legalizing centers for veterans and first responders to receive psilocybin and MDMA (a synthetic psychedelic) to treat mental health conditions like PTSD.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

NORML

AUGUST 13, 2019

Senate Bill 2023 expands the state’s medical cannabis program by adding several new qualifying conditions, allowing physicians assistants and advanced practice registered nurses to recommend medical cannabis to their patients, allowing minor patients to have up to three caregivers instead of two, among other changes.

Law 160

Law Education Conditions Programs 160

Canna Law Blog

MARCH 11, 2024

First introduced in 2023, HB 1453 sought to harmonize the existing medical exemptions from general sales and use taxes with the 37% excise tax on cannabis sales. Primarily, medical cannabis is not recreational or a luxury, but a necessity for many people who suffer from chronic pain, epilepsy, PTSD, and other conditions.

Chronic Pain 102

Chronic Pain Recreational Patients Medicine 102

MMJ Recs

JANUARY 20, 2024

Maryland, a trailblazer in progressive healthcare policies, has been part of this trend. Legalization of Recreational Cannabis in Maryland As of July 2023, the purchase of recreational marijuana was legalized in Maryland after voters approved a ballot referendum in the 2022 General Election to allow use of cannabis by adults aged 21 and over.

Law 52

Law Marijuana Patients Chronic Pain 52

Cannabis Law Report

FEBRUARY 28, 2022

The Board is made up of people who were appointed by the governor to create recommendations for the rules for the state’s legal psilocybin services, which begin in January 2023. Members of the Oregon Psilocybin Advisory Board (OPAB) are appointed by the Governor to serve four-year terms.

Research and Development 105

Research and Development Safety Policy Conditions 105

The Blunt Truth

JUNE 5, 2023

On May 25, 2023, the U.S. The Court also held that there is no common law claim for wrongful failure to hire in violation of public policy in New Jersey. Factual Background The plaintiff, an applicant for a position in the employer’s Asset Protection Department, received an offer of employment conditioned on him passing a drug test.

Policy 98

Policy Legislation Law Recreational 98

Canna Law Blog

AUGUST 9, 2023

On August 7, 2023, Judge Kevin Bryant in New York Supreme Court, County of Albany, ordered that the New York Cannabis Control Board (“CCB”) and Office of Cannabis Management (“OCM”) are restrained from awarding or further processing any more Conditional Adult-Use Retail Dispensary (“CAURD”) licenses.

Retail 60

Retail Dispensary Programs Policy 60

Veriheal

AUGUST 29, 2023

On the 19th of July, 2023, the Office of Cannabis Management in New York approved plans to permit cannabis ‘showcases’ and sales at public events. In fact, the conditions for these showcases are not necessarily stringent. During the approval of the Cannabis Grower Showcase, 212 conditional adult-use licenses were granted.

Events 75

Events Programs Retail Cultivation 75

The Blunt Truth

JULY 5, 2023

Starting August 1, 2023, Minnesota will provide protections to individuals who use cannabis for recreational purposes, after Minnesota Governor Tim Walz signed a state law allowing adults 21 and older to use recreational cannabis. Does the law require employers to have a drug or cannabis testing policy?

Law 52

Law Recreational Policy Treatment 52

Canna Law Blog

MARCH 17, 2023

Here’s the fulcrum of the policy argument (setting aside the technical constitution and procedural argument): “Defendants-Respondents’ arbitrary and capricious foray into legislative policymaking has (i) harmed those individuals the MRTA was designed to benefit (e.g., Here comes more New York cannabis program litigation.

Retail 73

Retail Dispensary Programs Cannabis 73

The Blunt Truth

MAY 11, 2023

More recently, on May 9, 2023, Washington Governor Jay Inslee signed similar legislation relating to initial hiring decisions. The California Civil Rights Division is expected to issue regulations, but whether those regulations will be finalized before the end of 2023 is unclear. What does this mean?

Law 97

Law THC Safety Cannabis 97

Cannabis Law Report

AUGUST 17, 2022

The act authorizes the use of marijuana by those suffering from an enumerated list of 20 medical conditions, including cancer, Crohn’s disease, post-traumatic stress disorder, and any “chronic, terminal, or debilitating” condition. However, its employment protections will likely not be applicable until July 2023.

Compliance 52

Compliance Compliance Marijuana Safety 52

The Blunt Truth

AUGUST 22, 2022

Employers can maintain a reasonable drug-free workplace policy that: Requires post-accident or reasonable suspicion drug testing of all employees or random drug testing of safety-sensitive workers; Is necessary to comply with federal law or a federal contract or funding agreement, if applicable to the employer; or. Next Steps for Employers.

Safety 111

Safety Environment Policy Recreational 111

MJ Business Attorneys

JULY 29, 2019

The letter accused Curaleaf of “illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases.” CBD sales by 2023. billion is U.S.

CBD 133

CBD Pets Media Food 133

Cannabis Law Report

JANUARY 27, 2022

The task force will complete a study and provide policy recommendations that will serve as a basis for substantive policy reforms during the 2023 legislative session. Policy Considerations for the Task Force. Task Force Members. The Psilocybin Equity task force currently calls for 14 members.

Research and Development 52

Research and Development Policy Access Legislation 52

Canna Law Blog

JULY 31, 2023

This year, the Oregon Liquor and Cannabis Commission (OLCC) likely will look at, to start: temporary rules it had adopted under the Governor’s clumsy tax compliance mandate; the 2023 legislative session’s new cannabis laws ; leftover business from the 2022 session; and certain COVID-era policies.

Compliance 90

Compliance Compliance Topical Retail 90

Cannabis Law Report

OCTOBER 4, 2021

A multitude of recent clinical trials shows the clear promise of psilocybin for this population suffering from these debilitating conditions. Adult Oregonians will be able to access psilocybin therapy under the PSA beginning in January 2023; patients with advanced illness are among those who may benefit from this therapy.

Therapy 52

Therapy Patients Law Clinical Trials 52

Cannabis Law Report

JANUARY 12, 2022

Marijuana was once again one of the hottest legislative topics across the nation in 2021, and while some states’ new legislation provided greater protections to employers with drug-free and/or zero-tolerance policies, others took a more employee-friendly approach. Puerto Rico.

Marijuana 52

Marijuana Policy Recreational Safety 52

Canna Law Blog

JULY 14, 2023

On July 5, 2023, the FDA and FTC jointly announced six cease and desist letters to alleged delta-8 product makers. FTC Policy Statement on Deception, 103 F.T.C. For now, stay tuned to the Canna Law Blog for more updates on FDA and FTC cannabinoid policies and delta-8 products. You can access the letters here. 174, 176 n.9

Packaging 74

Packaging Food Edibles THC 74

Cannabis Law Report

FEBRUARY 16, 2022

It’s called psilocybin — more commonly referred to as magic mushrooms — and it will be available to health care providers starting in 2023. . The use of psilocybin is meant to help treat conditions like depression, PTSD, addiction, severe anxiety, and more. February 15, 2022, 1:00 – 4:00 pm. .

Programs 52

Programs Treatment Policy Conditions 52

Veriheal

SEPTEMBER 2, 2022

Individuals in the country with conditions such as Parkinson’s disease, depression, insomnia, ADHD, multiple sclerosis, anxiety, chronic pain, and epilepsy have embraced the option of medical cannabis. This change in policy was sparked by the increase in authorizations in recent years.

Chronic Pain 57

Chronic Pain Patients Decriminalization Access 57

Veriheal

MARCH 29, 2023

However, a 2023 study debunks many myths about the potential dangers of legalizing cannabis. In some cases, legalization policies only allowed home-grown cannabis or had not yet implemented commercial sales. Always consult a physician before making any decision on the treatment of a medical condition.

Legalization 57

Legalization Data Policy Cannabis 57

Veriheal

NOVEMBER 6, 2020

A “Yes on Measure 110” campaign that helped bring awareness to this effort was funded by the Drug Policy Alliance, an advocacy group based out of New York. With the passing of Measure 110, this fund is said to see an increase of $91 million a year from 2021 through 2023. The Fight Back Against the Failed War on Drugs.

Decriminalization 76

Decriminalization Treatment Advocacy Policy 76

Cannabis Law Report

SEPTEMBER 22, 2022

Still before Governor Newsom for his signature is SB 1496 , which would implement a series of changes to the state’s cannabis tax policy, including authorizing regulators to extend the deadline for tax payments by cannabis businesses located in areas affected by an emergency proclamation by the Governor. FOOTNOTES. [1]

Law 52

Law Events Packaging Pets 52

Veriheal

DECEMBER 27, 2022

Some research suggests that these substances could be used to treat mental health conditions like depression and anxiety. Researchers have taken a big step in understanding the connection between using psychedelics and feeling connected to nature in a study published in the journal Drug Science, Policy, and Law on Oct.

Research and Development 101

Research and Development Therapy Consumption DEA 101

Veriheal

JANUARY 12, 2023

Approximately 3,000 patients who suffer from debilitating conditions like chronic pain and epilepsy will partake in the project, which is due to end in March 2023. Another groundbreaking move occurred in March of last year when the European country’s medical cannabis pilot project kicked off.

Medicine 97

Medicine Chronic Pain Consumption Cannabis 97

Cannabis Law Report

AUGUST 23, 2022

Any other contractual financial obligation that is explicitly or implicitly a factor considered in, or is a condition of a HCA, shall not be enforceable.

Legislation 52

Legislation Consumption Policy Business 52

Cannabis Law Report

AUGUST 23, 2022

Employers can maintain a reasonable drug-free workplace policy that: Requires post-accident or reasonable suspicion drug testing of all employees or random drug testing of safety-sensitive workers; Is necessary to comply with federal law or a federal contract or funding agreement, if applicable to the employer; or. Next Steps for Employers.

Safety 52

Safety Environment Policy Recreational 52

Cannabis Law Report

JUNE 23, 2022

Kathy Hochul announced June 22 the selection of Social Equity Impact Ventures LLC, a minority-led investment team, to sponsor and manage New York’s $200-million Social Equity Cannabis Investment Program that was included in the state’s fiscal 2023 enacted state budget. ” Social Equity Cannabis Investment Fund.

Seed-To-Sale 52

Seed-To-Sale Programs Retail Dispensary 52

Cannabis Law Report

DECEMBER 16, 2021

The Centers for Disease Control and Prevention (CDC) published workplace guidance for creating marijuana policies and drug testing procedures for employed drivers, including education for drivers on marijuana’s effects on safe driving. 1, 2023, under the new law. Standardized methods must be implemented on or before Jan.

Cannabinoids 52

Cannabinoids Retail Policy Cultivation 52

Veriheal

APRIL 14, 2022

The pilot program, which involves participation from approximately 3,000 patients who suffer from debilitating conditions, extends until March 2023. The political roadblocks that are preventing cannabis policy from being updated may prevent the French medical cannabis industry from finding firm ground.

Cultivation 52

Cultivation Supply Chain Research and Development Programs 52

NORML

MAY 31, 2019

Legislation is pending, Senate Bill 236, to allow qualifying patients with certain debilitating conditions to use and safely access medical cannabis. Update : SB 2023 was approved by the House Judiciary Criminal Committee on 5/29/19. Send a message to your federal lawmakers in support of this important legislation. 6073 and H.

Legislation 111

Legislation Access Banking Hemp 111

Cannabis Law Report

AUGUST 16, 2021

The facility is expected to be operational in Q1 2023. Once closed, which will be subject to the execution of definitive agreements and satisfaction of regulatory and other conditions, management believes this acquisition would solidify the Company’s scaled position in this core market and would be accretive to EBITDA. Massachusetts.

Business 105

Business Dispensary Retail Cultivation 105

Cannabis Law Report

NOVEMBER 18, 2021

Forward–looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “should”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions.

Research and Development 52

Research and Development Seed-To-Sale Supply Chain Events 52

Cannabis Law Report

NOVEMBER 23, 2019

Several declarations have been published by the local government in this sense about the project, and several special conditions have been already attributed. CAMPUS KANNABEIRA represents an estimated overall investment of more than €20m in the triennium of 2019-2023.

Pharmaceutical 45

Pharmaceutical Research and Development Cultivation Environment 45

Cannabis Law Report

AUGUST 4, 2021

from the second half of 2021 onwards as the Group fully repaid in May and June 2021 its 2022 and 2023 Eurobonds and successfully purchased a significant portion of its 2024 and 2026 Eurobonds which were bearing much higher interest rates. Objectives for FY 2023 also remain unchanged and do not include any COVID-19 impact either.

Business 105

Business Research and Development Environment Food 105